Bank ABC Islamic - today announces its results for the first nine months ending 2025: The Bank closed the third quarter with ...

Silexion continues to advance operational readiness for its planned Phase 2/3 clinical trials of SIL204, with toxicology ...

TORONTO, Nov. 12, 2025 /CNW/ - Dye & Durham Limited (the "Company" or "Dye & Durham") (TSX: DND) today announced preliminary ...

Q3 2025 Earnings Call November 12, 2025 5:00 PM ESTCompany ParticipantsJenny MitchellMatthew Booth - President, CEO, ...

Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the ...

AMC Entertainment Holdings, Inc. continues to struggle with heavy debt and significant shareholder dilution despite a box ...

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204's exceptional efficacy across multiple human cancer cell ...

Cassava Sciences, Inc. (NASDAQ: SAVA, "Cassava", the "Company"), a biotechnology company focused on developing novel, investigational treatments for central nervous system (CNS) disorders such as ...

Gross profit increased by 26.6% year-over-year to $33.4 million from $26.4 million in the third quarter of 2024; gross profit margin was 17.3% in the third quarter of 2025 compared with 16.0% in last ...

Gross Originations, Revenue and Adjusted EBITDA Growth to Continue In Fourth QuarterRecent Capital Transaction Increases Liquidity and Strengthens Balance Sheet PLANO, Texas, Nov. 12, 2025 (GLOBE NEWS ...

These blue-chip companies have corrected over the past year but show improving fundamentals and clear earnings recovery potential in 2026.

Romania’s leading green developer of residential, mixed-use, and office real estate, recorded a turnover of 236.3 million euros in the first nine months of 2025, up 13% year-on-year (YoY), and a gross ...